Latest News

Immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect

In a lab devoted to increasing healthy lifespans, the transplant anti-rejection drug rapamycin showed unexpected health benefits and increased survival in a mouse model of a fatal mitochondrial defect. Children with the untreatable condition suffer from brain damage and muscle weakness, and rarely live beyond 6 or 7 years. The drug enables the body to bypass the mitochondrial defect by switching its metabolism to burn fats and amino acids instead of glucose, and thereby reduces toxic byproducts.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Pregnancy and PTSD: Surprising findings could help moms-to-be at risk

  • Baby physics

  • Couch potatoes may have smaller brains later in life

  • Your brain may be what interests that guy checking you out

  • Remember where you're going? How scent helps

  • Task-oriented rehab program does not result in greater recovery from stroke

  • Study sheds light on source of drug addicts risk-taking behavior

  • Exercise and meditation together help beat depression

  • Overconfidence, loss aversion are key predictors for investment mistakes

  • Two in five individuals with schizophrenia have attempted suicide

  •